The effects of Implanon® on menstrual bleeding patterns

European Journal of Contraception and Reproductive Health Care

Volumn 13, Issue SUPPL. 1, 2008, Pages 13-28

  Mansour, Diana ^a   Korver, Tjeerd ^b   Marintcheva Petrova, Maya ^b   Fraser, Ian S ^c  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b Global Clinical Research   (Netherlands)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Contraception; Discontinuation; Dysmenorrhoea; Etonogestrel; Implanon ; Irregular bleeding

Indexed keywords

ETONOGESTREL; 3 KETO DESOGESTREL; 3-KETO-DESOGESTREL; CONTRACEPTIVE AGENT; DESOGESTREL; HEMOGLOBIN;

AMENORRHEA; ARTICLE; BODY MASS; CLINICAL TRIAL; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DYSMENORRHEA; FEMALE FERTILITY; HORMONAL CONTRACEPTION; HUMAN; IMPLANT; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; MENSTRUATION; NULLIPARA; ORAL CONTRACEPTION; OUTCOME ASSESSMENT; PARITY; PATIENT COUNSELING; PATIENT EDUCATION; PRIORITY JOURNAL; SEXUAL BEHAVIOR; UNSPECIFIED SIDE EFFECT; ADOLESCENT; ADULT; CHEMICALLY INDUCED DISORDER; FEMALE; MENSTRUATION DISORDER; PATIENT; REVIEW;

ADOLESCENT; ADULT; CLINICAL TRIALS AS TOPIC; CONTRACEPTIVE AGENTS, FEMALE; DESOGESTREL; FEMALE; HEMOGLOBINS; HUMANS; MENSTRUATION DISTURBANCES; PATIENT DROPOUTS; PATIENT EDUCATION AS TOPIC;

EID: 40549120139     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.1080/13625180801959931     Document Type: Article

References (33)

1. d'Arcangues C, Odlind V, Fraser IS. Dysfunctional uterine bleeding induced by exogenous hormones. Presented at Steroid Hormones and Uterine Bleeding: Meeting on the Effects of Steroid Hormones and Endometrial Vasculature, Bethesda, MD, 1992.
2. Belsey EM. The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use. Contraception 1988;38:207-25.
3. Fraser IS, Weisberg E, Minehan E, et al. A detailed analysis of menstrual blood loss in women using Norplant and Nestorone progestogen-only contraceptive implants or vaginal rings. Contraception 2000;61:241-51.
4. Livingstone M, Fraser IS. Mechanisms of abnormal uterine bleeding. Hum Reprod Update 2002;8:60-7.
5. Hickey M, d'Arcangues C. Vaginal bleeding disturbances and implantable contraceptives. Contraception 2002;65:75-84.
6. Funk S, Miller MM, Mishell DR, Jr., et al. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception 2005;71:319-26.
7. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958;53:457-81.
8. Belsey EM, Farley TM. The analysis of menstrual bleeding patterns: A review. Contraception 1988;38:129-56.
9. Belsey EM, Machin D, d'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction. Contraception 1986;34:253-60.
10. Fraser IS. Bleeding arising from the use of exogenous steroids. Baillieres Best Pract Res Clin Obstet Gynaecol 1999;13:203-22.
11. Belsey EM, Pinol AP. Menstrual bleeding patterns in untreated women. Task force on long-acting systemic agents for fertility regulation. Contraception 1997;55:57-65.
12. Treloar AE, Boynton RE, Behn BG, et al. Variation of the human menstrual cycle through reproductive life. Int J Fertil 1967;12:77-126.
13. Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: A randomized comparative trial. Contraception 1994;49:56-72.
14. Sivin I, Stern J. Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380Ag intrauterine contraceptive devices: A multicenter study. International Committee for Contraception Research (ICCR). Fertil Steril 1994;61:70-7.
15. Belsey EM, Peregoudov S. Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. I. Regional variations. Contraception 1988;38:227-42.
16. Magalhaes J, Aldrighi JM, de Lima GR. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas. Contraception 2007;75:193-8.
17. National Collaborating Centre for Women's and Children's Health. Long-acting reversible contraception: The effective and appropriate use of long-acting reversible contraception. London, UK: National Institute for Health and Clinical Excellence; October, 2005.
18. Belsey EM. Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception. Contraception 1988;38:181-206.
19. Archer DF, Jensen JT, Johnson JV, et al. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: Phase 3 study results. Contraception 2006;74:439-45.
20. Grow DR. Metabolism of endogenous and exogenous reproductive hormones. Obstet Gynecol Clin North Am 2002;29:425-36.
21. Belsey EM, d'Arcangues C, Carlson N. Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. II. The influence of individual characteristics. Contraception 1988;38:243-57.
22. Vincent AJ, Salamonsen LA. The role of matrix metalloproteinases and leukocytes in abnormal uterine bleeding associated with progestin-only contraceptives. Hum Reprod 2000;15:135-43.
23. Mascarenhas L, van Beek A, Bennink HC, et al. A 2-year comparative study of endometrial histology and cervical cytology of contraceptive implant users in Birmingham, UK. Hum Reprod 1998;13:3057-60.
24. Charnock-Jones DS, Macpherson AM, Archer DF, et al. The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium. Hum Reprod 2000;15:85-95.
25. Van den Bosch T, Donders GG, Riphagen I, et al. Ultrasonographic features of the endometrium and the ovaries in women on etonogestrel implant. Ultrasound Obstet Gynecol 2002;20:377-80.
26. Abdel-Aleem H, d'Arcangues C, Vogelsong K, et al. Treatment of vaginal bleeding irregularities induced by progestin only contraceptives. Cochrane Database Syst Rev 2007;CD003449.
27. Alvarez-Sanchez F, Brache V, Thevenin F, et al. Hormonal treatment for bleeding irregularities in Norplant implant users. Am J Obstet Gynecol 1996;174:919-22.
28. Diaz S, Croxatto HB, Pavez M, et al. Clinical assessment of treatments for prolonged bleeding in users of Norplant implants. Contraception 1990;42:97-109.
29. Cheng L, Zhu H, Wang A, et al. Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel. Hum Reprod 2000;15:1969-72.
30. Verbost PM, Hanssen RG, Korver GH, et al. ORG 33628 and ORG 31710 to control vaginal bleeding in progestin-only contraceptive regimens. Semin Reprod Med 2005;23:101-11.
31. Weisberg E, Hickey M, Palmer D, et al. A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon. Hum Reprod 2006;21:295-302.
32. Abdel-Aleem H, Shaaban OM, Amin AF, et al. Tamoxifen treatment of bleeding irregularities associated with Norplant use. Contraception 2005;72:432-7.
33. d'Arcangues C, Piaggio G, Brache V, et al. Effectiveness and acceptability of vitamin E and low-dose aspirin, alone or in combination, on Norplant-induced prolonged bleeding. Contraception 2004;70:451-62.